Neumarker
Founded 2022 · 20 employees on LinkedIn · 1 known investors
Find your way into Neumarker
112 people in our graph share verified history with the Neumarker team — schools, employers, funds. One of them is your warm intro.
Mike Gibbsunlockedknows Qiang Li · together at Neumarker (overlapped)
knows the team · via CloudMinds Technology Inc.
×7knows the team · via UTStarcom
×3knows the team · via Santa Clara University
Neumarker develops machine learning and biophysical tools to advance neuropsychiatric drug development and clinical care for CNS disorders. The company serves pharmaceutical and clinical organizations working on psychiatric and neurological treatments.
Founders & leadership
Neumarker was founded in 2022 by Ken Wang and Qiang Li.
QL

Qiang LiCo-founder and Chief Technology OfficerHe previously held a Vice President of Engineering role in software development, with expertise in embedded software, mobile applications, and Unix/Linux systems.
Investors · 1
Foothill Ventureslisted by Foothill VenturesLos Altos · $100K – $10M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Neumarker do?
- Neumarker develops machine learning and biophysical tools to advance neuropsychiatric drug development and clinical care for CNS disorders. The company serves pharmaceutical and clinical organizations working on psychiatric and neurological treatments.
- Who founded Neumarker?
- Neumarker was founded by Ken Wang, Qiang Li in 2022.
- Who are Neumarker's investors?
- Neumarker's investors include Foothill Ventures.



